Yiheng Capital Management Portfolio holdings
Top Buys
| 1 |
JD.com
JD
|
+$45.3M |
| 2 |
indie Semiconductor
INDI
|
+$9.17M |
| 3 |
Bilibili
BILI
|
+$8.2M |
| 4 |
Beam Therapeutics
BEAM
|
+$2.59M |
| 5 |
AKRO
Akero Therapeutics
AKRO
|
+$935K |
Top Sells
| 1 |
New Oriental
EDU
|
+$72.2M |
| 2 |
TAL Education Group
TAL
|
+$6.08M |
| 3 |
TransDigm Group
TDG
|
+$3.69M |
| 4 |
SQNS
Sequans Communications SA
SQNS
|
+$1.3M |
| 5 |
MYND
Mynd.ai
MYND
|
+$422K |
Sector Composition
| 1 | Consumer Discretionary | 13.17% |
| 2 | Communication Services | 9.97% |
| 3 | Healthcare | 7.81% |
| 4 | Technology | 7.5% |
| 5 | Consumer Staples | 7.07% |
Similar funds
Yiheng Capital Management's Q3 2023 Portfolio in Review
As of Q3 2023, Yiheng Capital Management held 37 positions worth $1.96B, up 6% from $1.85B the previous quarter. Its ten largest holdings account for 79% of the portfolio.
Yiheng Capital Management deployed $256M of net new capital in Q3 2023, opening 6 new positions and adding to 8 existing holdings. Its largest new stake was DBV Technologies: 13,319 shares worth $181K.
By sector, the portfolio is most concentrated in Consumer Discretionary at 13% of assets, up from 13% a quarter earlier, followed by Communication Services and Healthcare.
On the sell side, the largest reduction was New Oriental, an estimated $72.2M trimmed.
- Yiheng Capital Management's largest Q3 2023 buy was DBV Technologies: 13,319 shares worth $181K.
- Yiheng Capital Management added most to JD.com in Q3 2023, an estimated $45.3M increase.
- Yiheng Capital Management's biggest Q3 2023 reduction was New Oriental, cutting an estimated $72.2M.
- Yiheng Capital Management fully exited Sequans Communications SA in Q3 2023, selling an estimated $1.3M.
- Yiheng Capital Management's ten largest holdings make up 79% of its $1.96B portfolio in Q3 2023.
- Yiheng Capital Management opened 6 new positions and closed 2 in Q3 2023.
- Yiheng Capital Management's portfolio value rose 6% quarter-over-quarter to $1.96B.
Based on Yiheng Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.